Gene · 5209
Papers3,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crosstalk between neutrophil extracellular traps and immune regulation: insights into pathobiology and therapeutic implications of transfusion-related acute lung injury. | Front Immunol | 2023 | 38162674 | PubTator, text mining | PubMed |
| Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link. | J Clin Transl Hepatol | 2023 | 38161503 | PubTator, text mining | PubMed |
| The current status and future of PD-L1 in liver cancer. | Front Immunol | 2023 | 38155974 | PubTator, text mining | PubMed |
| UBC9 stabilizes PFKFB3 to promote aerobic glycolysis and proliferation of glioblastoma cells. | Int J Biochem Cell Biol | 2023 | 38149579 | PubTator, text mining | PubMed |
Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum. | Theranostics | 2023 | 38149301 | PubTator, text mining | PubMed |
| Metabolic changes with the occurrence of atherosclerotic plaques and the effects of statins. | Front Immunol | 2023 | 38143759 | PubTator, text mining | PubMed |
| Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma. | Int J Mol Sci | 2023 | 38139462 | PubTator, text mining | PubMed |
| The Role of Tumor Metabolic Reprogramming in Tumor Immunity. | Int J Mol Sci | 2023 | 38139250 | PubTator, text mining | PubMed |
| Metabolic Modulators in Cardiovascular Complications of Systemic Lupus Erythematosus. | Biomedicines | 2023 | 38137363 | PubTator, text mining | PubMed |
| Repurposing Metabolic Inhibitors in the Treatment of Colon Adenocarcinoma Patient-Derived Models. | Cells | 2023 | 38132178 | PubTator, text mining | PubMed |
| Differentially expressed genes in orbital adipose/connective tissue of thyroid-associated orbitopathy. | PeerJ | 2023 | 38130930 | PubTator, text mining | PubMed |
| An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancer. | Front Immunol | 2023 | 38124743 | PubTator, text mining | PubMed |
| Association between glycolysis markers and prognosis of liver cancer: a systematic review and meta-analysis. | World J Surg Oncol | 2023 | 38114977 | PubTator, text mining | PubMed |
Upregulation of Hsp27 via further inhibition of histone H2A ubiquitination confers protection against myocardial ischemia/reperfusion injury by promoting glycolysis and enhancing mitochondrial function. | Cell Death Discov | 2023 | 38114486 | PubTator, text mining | PubMed |
| Transcriptomic meta-analysis reveals ERRα-mediated oxidative phosphorylation is downregulated in Fuchs' endothelial corneal dystrophy. | PLoS One | 2023 | 38096202 | PubTator, text mining | PubMed |
| Research progress on the mechanism of glycolysis in ovarian cancer. | Front Immunol | 2023 | 38090580 | PubTator, text mining | PubMed |
| Unraveling the Sweet Secrets of HCC: Glucometabolic Rewiring in Hepatocellular Carcinoma. | Technol Cancer Res Treat | 2023 | 38083797 | PubTator, text mining | PubMed |
| The emerging role of glycolysis and immune evasion in gastric cancer. | Cancer Cell Int | 2023 | 38071310 | PubTator, text mining | PubMed |
| Krüppel-like Factor-9 and Krüppel-like Factor-13: Highly Related, Multi-Functional, Transcriptional Repressors and Activators of Oncogenesis. | Cancers (Basel) | 2023 | 38067370 | PubTator, text mining | PubMed |
| Macrophage LMO7 deficiency facilitates inflammatory injury via metabolic-epigenetic reprogramming. | Acta Pharm Sin B | 2023 | 38045056 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5209/papers?page=19